Astellas

Business

Astellas Pharma Non-GAAP EPS of ¥84.19, revenue of ¥1603.67B; initiates FY24 guidance

Astellas Pharma press release (OTCPK:ALPMF): FY Non-GAAP EPS of Â¥84.19. Revenue of Â¥1603.67B (+5.6% Y/Y). Net cash flows from operating…

Read More »
Back to top button